# Study to Estimate the Relative Bioavailability Compared to Commercial Extended-release Tablet Formulation and the Effects of Food Or Sprinkling on Applesauce for Fesoterodine Sustained-release Beads-in-capsule Formulations in Healthy Adult Volunteers

> **NCT02160158** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 24 (estimated)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Fesoterodine ER (fasted)
- **DRUG:** Fesoterodine SR3 (fasted)
- **DRUG:** Fesoterodine SR3 (fed)
- **DRUG:** Fesoterodine ER (fed)
- **DRUG:** Fesoterodine SR3 (sprinkle)
- **DRUG:** Fesoterodine ER (fasted)
- **DRUG:** Fesoterodine SR4 (fasted)
- **DRUG:** Fesoterodine SR4 (fed)
- **DRUG:** Fesoterodine ER (fed)
- **DRUG:** Fesoterodine SR4 (sprinkle)

## Key facts

- **NCT ID:** NCT02160158
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-07
- **Primary completion:** 2014-12
- **Final completion:** 2014-12
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2015-01-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02160158

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02160158, "Study to Estimate the Relative Bioavailability Compared to Commercial Extended-release Tablet Formulation and the Effects of Food Or Sprinkling on Applesauce for Fesoterodine Sustained-release Beads-in-capsule Formulations in Healthy Adult Volunteers". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02160158. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*